Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancers|September 28, 2023
The Association between Immune Checkpoint Proteins and Therapy Outcomes in Acute Myeloid Leukaemia PatientsLukasz Bolkun, Marlena Tynecka, Alicja Walewska, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignanciesAnna Szmigielska-Kaplon, Janusz Szemraj, Katarzyna Hamara, et al.
Annals of Hematology|May 3, 2013
The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disordersAnna Szmigielska-Kaplon, Anna Krawczynska, Magdalena Czemerska, et al.
Archives of Medical Science : AMS|May 24, 2021
The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patientsAgnieszka Pluta, Tadeusz Robak, Barbara Cebula, et al.
Leukemia & Lymphoma|January 1, 2015
Prognostic value of inhibitor of apoptosis protein family expression in patients with acute myeloid leukemiaAgnieszka Pluta, Agnieszka Wierzbowska, Barbara Cebula-Obrzut, et al.
Contemporary Oncology (Poznan, Poland)|October 18, 2024
Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome - a retrospective analysis of the Polish Adult Leukemia GroupAleksandra Gołos, Damian Mikulski, Monika Grobelska-Kowalik, et al.
Hematology (Amsterdam, Netherlands)|August 13, 2021
Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients - results of the PALG study 'PolAZA'Krzysztof Mądry, Karol Lis, Andrzej Tukiendorf, et al.
American Journal of Hematology|January 20, 2017
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trialAgnieszka Pluta, Tadeusz Robak, Agata Wrzesien-Kus, et al.
Leukemia & Lymphoma|October 30, 2019
Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)Agnieszka Pluta, Tadeusz Robak, Kamil Brzozowski, et al.
Pageof 2